Status:
COMPLETED
Coronary Chronic Total Occlusion and Oxidative Balance
Lead Sponsor:
Kahramanmaras Sutcu Imam University
Conditions:
Progression of Atherosclerotic Plaque
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
The presence of chronic blockage of coronary arteries, which we may accept as the terminal point of atherosclerotic coronary artery disease, is closely associated with a poor prognosis. The Discovery ...
Detailed Description
Chronic total occlusion (CTO) is defined as the complete blockage of the coronary artery characterized by a TIMI 0 flow present for at least 3 months. The presence of chronic blockage of coronary arte...
Eligibility Criteria
Inclusion
- Those who underwent coronary angiography with the diagnosis of stable coronary artery disease
- Elder than 18 years
- Patients who were not have the exclusion criterias
Exclusion
- Being under the age of 18,
- Unstable angina pectoris,
- Left ventricular systolic dysfunction (Ejection fraction \<50),
- Severe anemia
- pregnancy,
- History of congenital heart disease,
- Thyroid disorders,
- Sepsis,
- Malignancy,
- Chronic hematological disease,
- Malnutrition,
- Collagen tissue disease,
- Obesity (The Body Mass Index \>(BMI 30 kg/m2) ,
- moderate to severe liver failure,
- Renal deficiency (Glomerular filtration rate \<60 ml/min/1.73m2),
- Severe heart valve disease,
- Slectrolyte disorders,
- Receiving multivitamin and antioxidant supplementation treatment
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04754880
Start Date
January 1 2018
End Date
December 31 2019
Last Update
February 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ekrem Aksu
Kahramanmaraş, Turkey (Türkiye), 46050